Real-world evidence to support Payer/HTA decisions about highly innovative technologies in the EU—actions for stakeholders

There are divergent views on the potential of real-world data (RWD) to inform decisions made by regulators, health technology assessment (HTA) bodies, payers, clinicians, and patients. This RWE4Decisions initiative explored the particularly challenging setting of highly innovative technologies, whic...

Full description

Saved in:

Bibliographic Details
Published in:	International journal of technology assessment in health care Vol. 36; no. 4; pp. 459 - 468
Main Authors:	Facey, Karen M., Rannanheimo, Piia, Batchelor, Laura, Borchardt, Marine, de Cock, Jo
Format:	Journal Article
Language:	English
Published:	New York, USA Cambridge University Press 01.08.2020
Subjects:	Case studies Collaboration Decision analysis Decision making Disease Initiatives Learning Life cycles Meetings Pharmaceutical industry Policy Rare diseases Regulators Regulatory approval Reimbursement Stakeholders Task forces Technology Technology assessment Workshops United States > US Decision making Reimbursement mechanisms Real-world data Stakeholder participation Real-world evidence
ISSN:	0266-4623, 1471-6348, 1471-6348
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!